The Registry of Toxic Effects of Chemical Substances
Phenol |
UPDATE: February 2005 | MW: 94.12 | MF: C6H6O |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
eye | rabbit
5 mg
|
severe
|
UCDS** 1/6/1966
|
eye | rabbit
5 mg/30S rinse
|
mild
|
TXCYAC 23,281,1982
|
skin | rabbit
500 mg/24 hour
|
severe
|
BIOFX* 27-4/1973
|
skin | rabbit
535 mg open irritation test
|
severe
|
UCDS** 1/6/1966
|
skin | rabbit
100 mg
|
mild
|
KSGZA3 33,518,1980
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
cytogenetic analysis
|
hamster
ovary
|
2 gm/L
|
SCIEAS 236,933,1987
|
cytogenetic analysis
|
hamster
embryo
|
100 µmol/L
|
MUREAV 373,113,1997
|
cytogenetic analysis
|
multiple | other fish
300 nL/L
|
JFIBA9 26,13,1985
|
DNA damage
|
mammal (species unspecified)
lymphocyte
|
250 mmol/L
|
PNASA6 48,686,1962
|
DNA damage
|
mouse
lymphocyte
|
1,500 µmol/L
|
MUREAV 203,155,1988
|
DNA inhibition
|
hamster
lung
|
1,900 µmol/L
|
MUTAEX 3,51,1988
|
DNA inhibition
|
human
HeLa cell
|
1 mmol/L
|
SAIGBL 16,453,1974
|
DNA inhibition
|
oral | mouse
20 gm/kg
|
ARGEAR 51,605,1981
|
DNA inhibition
|
mouse
lymphocyte
|
800 µmol/L
|
MOPMA3 28,560,1985
|
unscheduled DNA synthesis
|
hamster
embryo
|
3 µmol/L
|
MUREAV 373,113,1997
|
unscheduled DNA synthesis
|
oral | rat
4 gm/kg
|
JJIND8 74,1283,1985
|
mutation in microorganisms
|
mouse
lymphocyte
|
300 mg/L (+enzymatic activation step)
|
SCIEAS 236,933,1987
|
mutation in microorganisms
|
other microorganisms
|
200 mg/L/8 hour (-enzymatic activation step)
|
MUREAV 492,13,2001
|
mutation in microorganisms
|
Salmonella typhimurium
|
40 µmol/plate (-enzymatic activation step)
|
MUREAV 90,91,1981
|
micronucleus test
|
hamster
lung
|
4 mmol/L
|
EVHPAZ 82,81,1989
|
micronucleus test
|
hamster
ovary
|
175 mg/L
|
EMMUEG 26,240,1995
|
micronucleus test
|
hamster
embryo
|
500 mg/L/4 hour (+enzymatic activation step)
|
MUREAV 561,153,2004
|
micronucleus test
|
oral | mouse
265 mg/kg
|
MUREAV 208,61,1988
|
micronucleus test
|
intraperitoneal | mouse
265 mg/kg
|
MUREAV 209,23,1988
|
gene conversion and mitotic recombination
|
Aspergillus nidulans
|
15 µmol/L
|
MUTAEX 2,235,1987
|
mutation in mammalian somatic cells
|
hamster
embryo
|
3 mmol/L
|
MUREAV 373,113,1997
|
mutation in mammalian somatic cells
|
mouse
lymphocyte
|
1,890 µmol/L
|
MUTAEX 3,193,1988
|
morphological transform
|
hamster
embryo
|
10 µmol/L
|
MUREAV 373,113,1997
|
other mutation test systems
|
human
HeLa cell
|
17 mg/L
|
WATRAG 19,677,1985
|
other mutation test systems
|
human
lymphocyte
|
5 µmol/L
|
CNREA8 45,2471,1985
|
other mutation test systems
|
mouse
other cell types
|
2,500 µmol/L
|
CBTOE2 2,231,1986
|
other mutation test systems
|
rabbit
bone marrow
|
250 µmol/L
|
AJIMD8 7,485,1985
|
sister chromatid exchange
|
hamster
ovary
|
300 mg/L
|
SCIEAS 236,933,1987
|
sister chromatid exchange
|
hamster
embryo
|
1 mmol/L
|
MUREAV 373,113,1997
|
sister chromatid exchange
|
human
lymphocyte
|
5 µmol/L
|
CNREA8 45,2471,1985
|
sex chromosome loss and nondisjunction
|
Drosophila melanogaster
ovary
|
100 ppm
|
NATUAS 157,162,1946
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | rat
lowest published toxic dose: 600 mg/kg (12-14 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
TXAPA9 19,373,1971
|
oral | mouse
lowest published toxic dose: 2,300 mg/kg (6-15 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on embryo or fetus: Fetal death
NTIS** PB85-104461
|
oral | mouse
lowest published toxic dose: 2,600 mg/kg (6-15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
NTIS** PB85-104461
|
oral | mouse
lowest published toxic dose: 4 gm/kg (6-15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Musculoskeletal system
|
NTIS** PB85-104461
|
oral | mouse
lowest published toxic dose: 2,800 mg/kg (6-15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
TJADAB 33,92C,1986
|
oral | mouse
lowest published toxic dose: 2,800 mg/kg (6-15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
NTIS** #PB83-247726
|
oral | rat
lowest published toxic dose: 300 mg/kg (6-15 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants)
|
NTIS** PB83-247726
|
oral | rat
lowest published toxic dose: 1,200 mg/kg (6-15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
NTIS** PB83-247726
|
oral | rat
lowest published toxic dose: 3,600 mg/kg (6-15 day pregnant)
|
Reproductive: Other effects on female | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
NTIS** OTS0573554
|
oral | rat
lowest published toxic dose: 1,200 mg/kg (6-15 day pregnant)
|
Reproductive: Other effects on female
|
NTIS** OTS0537777
|
oral | rat
lowest published toxic dose: 300 mg/kg (6-15 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
NTIS** #PB83-247726
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
skin | mouse
lowest published toxic dose: 16 gm/kg/40 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Skin and Appendages: Tumors
CNREA8 19,413,1959
|
skin | mouse
toxic dose : 4,000 mg/kg/24 week- intermittent
|
Tumorigenic: Neoplastic by RTECS criteria | Skin and Appendages: Tumors
CNREA8 19,413,1959
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | mouse
lethal concentration (50 percent kill): 177 mg/m3
|
N/R
|
GISAAA 41(6),103,1976
|
inhalation | mouse
lowest published toxic concentration: 15 ppm/6 minute
|
Lung, Thorax, or Respiration: Respiratory depression
|
TOLED5 9,137,1981
|
inhalation | mouse
lethal concentration (50 percent kill): 177 mg/m3/4 hour
|
N/R
|
VCVGK* -,197,1994
|
inhalation | mouse
lethal concentration : 110 mg/m3/4 hour
|
N/R
|
VCVGK* -,197,1994
|
inhalation | rat
lethal concentration (50 percent kill): 316 mg/m3
|
N/R
|
GISAAA 41(6),103,1976
|
inhalation | rat
lethal concentration (50 percent kill): 316 mg/m3/4 hour
|
N/R
|
VCVGK* -,197,1994
|
inhalation | rat
lethal concentration : 232 mg/m3/4 hour
|
N/R
|
VCVGK* -,197,1994
|
inhalation | rat
lowest published toxic concentration: 110 mg/m3/4 hour
|
Behavioral: Somnolence (general depressed activity) | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Proteases
VCVGK* -,197,1994
|
intraperitoneal | guinea pig
lowest published lethal dose: 300 mg/kg
|
N/R
|
HBTXAC 1,228,1955
|
intraperitoneal | mouse
lethal dose (50 percent kill): 180 mg/kg
|
N/R
|
PHMCAA 10,172,1968
|
intraperitoneal | mouse
lowest published toxic dose: 300 mg/kg
|
Nutritional and Gross Metabolic: Body temperature decrease
|
TOXID9 72,207,2003
|
intraperitoneal | rat
lethal dose (50 percent kill): 127 mg/kg
|
N/R
|
FCTOD7 22,665,1984
|
intraperitoneal | rabbit
lowest published lethal dose: 620 mg/kg
|
N/R
|
JPETAB 80,233,1944
|
intravenous | mouse
lethal dose (50 percent kill): 112 mg/kg
|
Behavioral: Tremor
|
QJPPAL 12,212,1939
|
intravenous | rabbit
lowest published lethal dose: 180 mg/kg
|
N/R
|
JPETAB 80,233,1944
|
oral | cat
lowest published lethal dose: 80 mg/kg
|
N/R
|
HBAMAK 4,1319,1935
|
oral | dog
lowest published lethal dose: 500 mg/kg
|
N/R
|
HBAMAK 4,1319,1935
|
oral | human
lowest published lethal dose: 14 gm/kg
|
Behavioral: Muscle weakness | Lung, Thorax, or Respiration: Cyanosis
34ZIAG -,463,1969
|
oral | human
lowest published lethal dose: 140 mg/kg
|
Behavioral: Hallucinations, distorted perceptions | Skin and Appendages: Other: Sweating
29ZWAE -,329,1968
|
oral | infant
lowest published lethal dose: 10 mg/kg
|
Behavioral: Muscle weakness | Lung, Thorax, or Respiration: Cyanosis
34ZIAG -,463,1969
|
oral | mammal (species unspecified)
lethal dose (50 percent kill): 500 mg/kg
|
N/R
|
GTPZAB 32(10),25,1988
|
oral | mouse
lethal dose (50 percent kill): 270 mg/kg
|
N/R
|
GISAAA 38(8),6,1973
|
oral | mouse
lowest published toxic dose: 265 mg/kg/12 hour
|
Blood: Changes in bone marrow not included in above
|
MUREAV 208,61,1988
|
oral | rat
lethal dose (50 percent kill): 317 mg/kg
|
Behavioral: Convulsions or effect on seizure threshold
|
PSEBAA 32,592,1935
|
oral | rat
lethal dose (50 percent kill): 512 mg/kg
|
N/R
|
VCVGK* -,197,1994
|
oral | rabbit
lowest published lethal dose: 420 mg/kg
|
N/R
|
JPETAB 80,233,1944
|
parenteral | frog
lowest published lethal dose: 290 mg/kg
|
Peripheral Nerve and Sensation: Spastic paralysis with/without sensory change | Behavioral: Convulsions or effect on seizure threshold Cardiac: Other changes
AEPPAE 166,437,1932
|
subcutaneous | cat
lowest published lethal dose: 80 mg/kg
|
N/R
|
JPETAB 80,233,1944
|
subcutaneous | frog
lowest published lethal dose: 75 mg/kg
|
N/R
|
HBAMAK 4,1319,1935
|
subcutaneous | frog
lowest published lethal dose: 290 mg/kg
|
N/R
|
HBTXAC 1,228,1955
|
subcutaneous | guinea pig
lowest published lethal dose: 450 mg/kg
|
N/R
|
HBTXAC 1,228,1955
|
subcutaneous | mouse
lethal dose (50 percent kill): 344 mg/kg
|
N/R
|
INHEAO 5,143,1967
|
subcutaneous | rat
lethal dose (50 percent kill): 460 mg/kg
|
N/R
|
TOIZAG 10,1,1963
|
subcutaneous | rabbit
lowest published lethal dose: 620 mg/kg
|
N/R
|
JPETAB 80,233,1944
|
skin | rat
lethal dose (50 percent kill): 669 mg/kg
|
Behavioral: Tremor | Kidney, Ureter, and Bladder: Hematuria Skin: After topical application: Cutaneous sensitization (experimental)
BJIMAG 27,155,1970
|
skin | rat
lethal dose (50 percent kill): 1,500 mg/kg
|
N/R
|
VCVGK* -,197,1994
|
skin | rabbit
lethal dose (50 percent kill): 630 mg/kg
|
N/R
|
UCDS** 1/6/1966
|
unreported route | cat
lowest published lethal dose: 250 mg/kg
|
N/R
|
RMSRA6 15,561,1895
|
unreported route | dog
lowest published lethal dose: 200 mg/kg
|
N/R
|
RMSRA6 15,561,1895
|
unreported route | man
lowest published toxic dose: 5,714 µg/kg
|
Olfaction: Other olfaction effects
|
VHTODE 41,151,1999
|
unreported route | rabbit
lowest published lethal dose: 150 mg/kg
|
N/R
|
RMSRA6 15,561,1895
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | rat
lowest published toxic concentration: 150 µg/m3/8 hour/26 week- intermittent
|
Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis) | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases
KHZDAN 16,33,1973
|
inhalation | rat
lowest published toxic concentration: 5 mg/m3/4 hour/17 week- intermittent
|
Liver: Liver function tests impaired | Endocrine: Effect on menstrual cycle Blood: Changes in leukocyte (WBC) count
GISAAA 37(10),105,1972
|
inhalation | rat
lowest published toxic concentration: 100 µg/m3/24 hour/61 day- continuous
|
Behavioral: Muscle contraction or spasticity | Blood: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
GISAAA 38(7),7,1973
|
inhalation | rat
lowest published toxic concentration: 0.5 mg/m3/4 hour/122 day- intermittent
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
VCVGK* -,197,1994
|
oral | mouse
lowest published toxic dose: 174 mg/kg/28 day- continuous
|
Brain and Coverings: Other degenerative changes | Blood: Changes in erythrocyte (RBC) count Immunological Including Allergic: Decreased immune response
EPEPEG 228,107,1992
|
oral | mouse
lowest published toxic dose: 2,800 mg/kg/10 day- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
NTIS** #PB83-247726
|
oral | mouse
lowest published toxic dose: 2,800 mg/kg/10 day- intermittent
|
Behavioral: Tremor | Behavioral: Ataxia
NTIS** #PB83-247726
|
oral | rat
lowest published toxic dose: 22,750 mg/kg/13 week- continuous
|
Behavioral: Food intake (animal) | Behavioral: Fluid intake Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TOXID9 48,359,1999
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
time-weighted average 5 ppm (skin)
|
DTLVS* TLV/BEI,2003
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
Not Classifiable as a Human Carcinogen
|
DTLVS* TLV/BEI,2003
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Inadequate Evidence
|
IMEMDT 47,263,1989
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Inadequate Evidence
|
IMEMDT 71,749,1999
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Inadequate Evidence
|
IMEMDT 47,263,1989
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Inadequate Evidence
|
IMEMDT 71,749,1999
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Group 3
|
IMEMDT 71,749,1999
|
TOXICOLOGY REVIEW
|
|
MUREAV 566,99,2004
|
TOXICOLOGY REVIEW
|
|
JIHTAB 31,146,1949
|
TOXICOLOGY REVIEW
|
|
MUREAV 47,75,1978
|
TOXICOLOGY REVIEW
|
|
FNSCA6 2,67,1973
|
TOXICOLOGY REVIEW
|
|
ZKKOBW 78,99,1972
|
TOXICOLOGY REVIEW
|
|
TOLED5 134,3,2002
|
TOXICOLOGY REVIEW
|
|
TOLED5 140-141,53,2003
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Environmental Protection Agency (EPA) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1988
|
PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION
|
FEREAC 54,7740,1989
|
Environmental Protection Agency (EPA) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1998 STATUS OF
|
PESTICIDES: Supported
|
RBREV* -,331,1998
|
Mine Safety and Health Administration (MSHA) STANDARD - air
|
time-weighted average 5 ppm (19 mg/m3) (skin)
|
DTLVS* 3,203,1971
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry)
|
8 hour time-weighted average 5 ppm (19 mg/m3) (skin)
|
CFRGBR 29,1910.1000,1994
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction)
|
8 hour time-weighted average 5 ppm (19 mg/m3) (skin)
|
CFRGBR 29,1926.55,1994
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards)
|
8 hour time-weighted average 5 ppm (19 mg/m3) (skin)
|
CFRGBR 29,1915.1000,1993
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors)
|
8 hour time-weighted average 5 ppm (19 mg/m3) (skin)
|
CFRGBR 41,50-204.50,1994
|
Occupational Exposure Limit - ARAB Republic of Egypt
|
time-weighted average 5 ppm (19 mg/m3), Skin, JAN1993
|
Occupational Exposure Limit - AUSTRALIA
|
time-weighted average 5 ppm (19 mg/m3), Skin, JAN1993
|
Occupational Exposure Limit - AUSTRIA
|
MAK 5 ppm (19 mg/m3), Skin, JAN1999
|
Occupational Exposure Limit - BELGIUM
|
time-weighted average 5 ppm (19 mg/m3), Skin, JAN1993
|
Occupational Exposure Limit - DENMARK
|
time-weighted average 1 ppm (4 mg/m3), Skin, JAN1999
|
Occupational Exposure Limit - FINLAND
|
time-weighted average 5 ppm (19 mg/m3), short term exposure limit 10 ppm (38 mg/m3), Skin, JAN1999
|
Occupational Exposure Limit - FRANCE
|
VME 5 ppm (19 mg/m3), Skin, JAN1999
|
Occupational Exposure Limit - GERMANY
|
MAK 5 ppm (19 mg/m3), Skin, JAN1999
|
Occupational Exposure Limit - THE NETHERLANDS
|
MAC-TGG 8 mg/m3, Skin, 2003
|
Occupational Exposure Limit - JAPAN
|
Occupational Exposure Limit 5 ppm (19 mg/m3), Skin, JAN1999
|
Occupational Exposure Limit - NORWAY
|
time-weighted average 1 ppm (4 mg/m3), JAN1999
|
Occupational Exposure Limit - THE PHILIPPINES
|
time-weighted average 5 ppm (10 mg/m3), Skin, JAN1993
|
Occupational Exposure Limit - POLAND
|
MAC(time-weighted average) 10 mg/m3, MAC(short term exposure limit) 20 mg/m3, JAN1999
|
Occupational Exposure Limit - RUSSIA
|
time-weighted average 5 ppm, short term exposure limit 0.3 mg/m3, Skin, JAN1993
|
Occupational Exposure Limit - SWEDEN
|
NGV 1 ppm (4 mg/m3), KTV 2 ppm (8 mg/m3), Skin, JAN1999
|
Occupational Exposure Limit - SWITZERLAND
|
MAK- week 5 ppm (19 mg/m3), KZG- week 10 ppm (38 mg/m3), Skin, JAN1999
|
Occupational Exposure Limit - THAILAND
|
time-weighted average 5 ppm (19 mg/m3), JAN1993
|
Occupational Exposure Limit - TURKEY
|
time-weighted average 5 ppm (19 mg/m3), Skin, JAN1993
|
Occupational Exposure Limit - UNITED KINGDOM
|
time-weighted average 5 ppm (20 mg/m3), short term exposure limit 10 ppm, Skin, SEP2000
|
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value; | Not Classifiable as a Human Carcinogen
Occupational Exposure Limit IN NEW ZEALAND, SINGAPORE, VIETNAM
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value |
Not Classifiable as a Human Carcinogen |
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO PHENOL-air
|
10 hour time-weighted average 5 ppm (Sk); | ceiling concentration 15.6 ppm/15 minute (Sk)
NIOSH* DHHS #92-100,1992
|
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: 55460; | Number of Industries 185; Total Number of Facilities 23,275; Number of Occupations 127; Total Number of Employees Exposed 296,662
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: 55460; |
Number of Industries 229; Total Number of Facilities 31,983; Number of Occupations 155; Total Number of Employees Exposed 584,372; Total Number of Female Employees Exposed 120,977 |
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
ATSDR TOXICOLOGY PROFILE (NTIS** PB/99/122012)
|
EPA GENETOX PROGRAM 1988, Negative: N crassa-reversion
|
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
Used as a pharmaceutical and veterinary drug
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
On EPA IRIS database
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
NIOSH Analytical Method, 1994: Cresol (all isomers) and phenol, 2546
|
NIOSH Analytical Method, 1994: Phenol, 3502; in urine, 8305
|
NCI Carcinogenesis Bioassay (oral);no evidence:mouse,rat
|
NCITR* NCI-TR-203,1980
|
OSHA ANALYTICAL METHOD #32
|
|
REFERENCES:
CODEN
|
|
REFERENCE
29ZWAE
|
"Practical Toxicology of Plastics," Lefaux, R., Cleveland, OH, Chemical Rubber Co., 1968
|
34ZIAG
|
"Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969
|
AEPPAE
|
Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.)
V.110-253, 1925-66. For publisher information, see NSAPCC.
|
AJIMD8
|
American Journal of Industrial Medicine. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY
10003) V.1- 1980-
|
ARGEAR
|
Archiv fuer Geschwulstforschung. (VEB Verlag Volk und Gesundheit Neue Gruenstr. 18, Berlin
DDR-1020, Ger. Dem. Rep.) V.1- 1949-
|
BIOFX*
|
BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook,
IL 60062)
|
BJIMAG
|
British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME
04046) V.1- 1944-
|
CBTOE2
|
Cell Biology and Toxicology. (Princeton Scientific Pub., Inc., 301 N. Harrison St., CN 5279,
Princeton, NJ 08540) V.1- 1984-
|
CFRGBR
|
Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents,
Washington, DC 20402)
|
CNREA8
|
Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA
19106) V.1- 1941-
|
DTLVS*
|
The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by
American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996
|
EMMUEG
|
Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY
10003) V.10- 1987-
|
EPEPEG
|
European Journal of Pharmacology, Environmental Toxicology and Pharmacology Section. (Elsevier
Science Publishers B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.228- 1992-
|
EVHPAZ
|
EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents,
Washington, DC 20402) No.1- 1972-
|
FCTOD7
|
Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford,
NY 10523) V.20- 1982-
|
FEREAC
|
Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402)
V.1- 1936-
|
FNSCA6
|
Forensic Science. (Lausanne, Switzerland) V.1-11, 1972-78. For pub lisher information, see
FSINDR.
|
GISAAA
|
Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga,
113095 Moscow, USSR) V.1- 1936-
|
GTPZAB
|
Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O
Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see
MTPEEI
|
HBAMAK
|
"Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.)
|
HBTXAC
|
"Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59
|
IMEMDT
|
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications
Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
|
INHEAO
|
Industrial Health. (National Institute of Industrial Health, 6-21-1 Nagao, Tama-ku, Kawasaki,
213 Japan) V.1- 1963-
|
JFIBA9
|
Journal of Fish Biology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-
1969-
|
JIHTAB
|
Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For
publisher information, see AEHLAU.
|
JJIND8
|
JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For
publisher information, see JNCIEQ.
|
JPETAB
|
Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E.
Preston St., Baltimore, MD 21202) V.1- 1909/10-
|
KHZDAN
|
Khigiena i Zdraveopazvane. Hygiene and Sanitation. (Hemus, Blvd. Russki 6, Sofia, Bulgaria)
V.9- 1966-
|
KSGZA3
|
Kyushu Shika Gakkai Zasshi. Journal of the Kyushu Dental Society. (c/o Kyushu Shika Daigaku,
2-6-1 Manazuru, Kokurakita-ku, Kitakyushu, Japan) V.1- 1933- Suspended 1941-50.
|
MOPMA3
|
Molecular Pharmacology. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202)
V.1- 1965-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
MUTAEX
|
Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ,
UK) V.1- 1986-
|
NATUAS
|
Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869-
|
NCITR*
|
National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205.
For publisher information, see NTPTR*.
|
NIOSH*
|
National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and
Welfare, Reports and Memoranda.
|
NTIS**
|
National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse
for Scientific & Technical Information.
|
PHMCAA
|
Pharmacologist. (American Soc. for Pharmacology and Experimental Therapeutics, 9650 Rockville
Pike, Bethesda, MD 20014) V.1- 1959-
|
PNASA6
|
Proceedings of the National Academy of Sciences of the United States of America. (National
Academy of Sciences, Printing & Pub. Office, 2101 Constitution Ave., Washington, DC 20418)
V.1- 1915-
|
PSEBAA
|
Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1903/04-
|
QJPPAL
|
Quarterly Journal of Pharmacy & Pharmacology. (London, UK) V.2-21, 1929-48. For publisher
information, see JPPMAB.
|
RBREV*
|
Status of Pesticides in Registration, Reregistration, and Special Review (Rainbow Report),
Special Review and Reregistration Division Office of Pesticide Programs U.S. Environmental
Protection Agency, 401 M. Street, S.W., Washington, D.C. 20460, Spring 1998
|
RMSRA6
|
Revue Medicale de la Suisse Romande. (Societe Medicale de La Suisse Romande, 2 rue
Bellefontaine, 1003 Lausanne, Switzerland) V.1- 1881-
|
SAIGBL
|
Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu
Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959-
|
SCIEAS
|
Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC
20005) V.1- 1895-
|
TJADAB
|
Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E.
11th St., New York, NY 10003) V.1- 1968-
|
TOIZAG
|
Toho Igakkai Zasshi. Journal of Medical Society of Toho University. (Toho Daigaku Igakkai,
21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143, Japan) V.1- 1954-
|
TOLED5
|
Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands)
V.1- 1977-
|
TOXID9
|
Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1-
1981-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
TXCYAC
|
Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973-
|
UCDS**
|
Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817)
|
VCVGK*
|
"Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia".
(Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia,
1994.
|
VHTODE
|
Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology,
Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977-
|
WATRAG
|
Water Research. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 0BW, UK) V.1- 1967-
|
ZKKOBW
|
Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92,
1971-78. For publisher information, see JCROD7.
|
|